[1]
H. V. A. M. and P. K. K. NAMBOORI, “DESIGN AND DEVELOPMENT OF A PHARMACOGENOMIC MODEL FOR BREAST CANCER TO STUDY THE VARIATION IN DRUG ACTION AND SIDE EFFECTS”, Int J App Pharm, vol. 14, no. 3, pp. 61–68, May 2022.